참고문헌 (54)

1. Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for？neurodegenerative disease. Nat Rev Neurol 2019;15:565-581. 

   상세보기

2. Azam S, Haque ME, Balakrishnan R, Kim IS, Choi DK. The ageing brain: molecular and cellular basis of？neurodegeneration. Front Cell Dev Biol 2021;9:683459. 

   상세보기

3. Bernadotte A, Mikhelson VM, Spivak IM. Markers of cellular senescence. Telomere shortening as a marker？of cellular senescence. Aging (Albany NY) 2016;8:3-11. 

4. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human chromosomes have long？G-rich telomeric overhangs at one end. Genes Dev 1997;11:2801-2809. 

   상세보기

5. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000;34:331-358. 

   상세보기

6. Sarek G, Kotsantis P, Ruis P, Van Ly D, Margalef P, Borel V, et al. CDK phosphorylation of TRF2 controls？t-loop dynamics during the cell cycle. Nature 2019;575:523-527. 

7. Koh SH, Choi SH, Jeong JH, Jang JW, Park KW, Kim EJ, et al. Telomere shortening reflecting physical？aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to？Alzheimer's disease. Aging (Albany NY) 2020;12:4407-4423. 

8. Wang J, Liu Y, Xia Q, Xia Q, Wang B, Yang C, et al. Potential roles of telomeres and telomerase in？neurodegenerative diseases. Int J Biol Macromol 2020;163:1060-1078. 

   상세보기

9. Kim EJ, Koh SH, Ha J, Na DL, Seo SW, Kim HJ, et al. Increased telomere length in patients with？frontotemporal dementia syndrome. J Neurol Sci 2021;428:117565. 

   상세보기

10. Fani L, Hilal S, Sedaghat S, Broer L, Licher S, Arp PP, et al. Telomere length and the risk of Alzheimer's？disease: the Rotterdam Study. J Alzheimers Dis 2020;73:707-714. 

11. Chow HM, Herrup K. Genomic integrity and the ageing brain. Nat Rev Neurosci 2015;16:672-684. 

    상세보기

12. Moller P. Genotoxicity of environmental agents assessed by the alkaline comet assay. Basic Clin？Pharmacol Toxicol 2005;96 Suppl 1:1-42. 

13. Jeppesen DK, Bohr VA, Stevnsner T. DNA repair deficiency in neurodegeneration. Prog Neurobiol？2011;94:166-200. 

14. McKinnon PJ. Maintaining genome stability in the nervous system. Nat Neurosci 2013;16:1523-1529. 

    상세보기

15. Hwang JY, Aromolaran KA, Zukin RS. The emerging field of epigenetics in neurodegeneration and？neuroprotection. Nat Rev Neurosci 2017;18:347-361. 

    상세보기

16. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell？2013;153:1194-1217. 

    상세보기

17. Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther？2012;342:619-630. 

18. Keogh MJ, Chinnery PF. Mitochondrial DNA mutations in neurodegeneration. Biochim Biophys Acta？2015;1847:1401-1411. 

19. Kultz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 2005;67:225-257. 

    상세보기

20. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010;24:2463-2479. 

21. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, et al. Spatial coupling of mTOR？and autophagy augments secretory phenotypes. Science 2011;332:966-970. 

    상세보기

22. Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat？Med 2014;20:870-880. 

    상세보기

23. Currais A. Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing？Res Rev 2015;21:30-42. 

    상세보기

24. Shin JS, Hong A, Solomon MJ, Lee CS. The role of telomeres and telomerase in the pathology of human？cancer and aging. Pathology 2006;38:103-113. 

    상세보기

25. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions.？Cell 1998;92:401-413. 

    상세보기

26. Takubo K, Nakamura K, Izumiyama N, Furugori E, Sawabe M, Arai T, et al. Telomere shortening with？aging in human liver. J Gerontol A Biol Sci Med Sci 2000;55:B533-B536. 

27. Herrmann M, Pusceddu I, Marz W, Herrmann W. Telomere biology and age-related diseases. Clin Chem？Lab Med 2018;56:1210-1222. 

28. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in？blood and mortality in people aged 60 years or older. Lancet 2003;361:393-395. 

29. Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB. Comparisons of telomere lengths in peripheral？blood and cerebellum in Alzheimer's disease. Alzheimers Dement 2009;5:463-469. 

30. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, et al. Telomere shortening in T？cells correlates with Alzheimer's disease status. Neurobiol Aging 2003;24:77-84. 

    상세보기

31. Scarabino D, Broggio E, Gambina G, Corbo RM. Leukocyte telomere length in mild cognitive impairment？and Alzheimer's disease patients. Exp Gerontol 2017;98:143-147. 

    상세보기

32. Lee EH, Han MH, Ha J, Park HH, Koh SH, Choi SH, et al. Relationship between telomere shortening and？age in Korean individuals with mild cognitive impairment and Alzheimer's disease compared to that in？healthy controls. Aging (Albany NY) 2020;13:2089-2100. 

33. Liu M, Huo YR, Wang J, Wang C, Liu S, Liu S, et al. Telomere shortening in Alzheimer's disease patients.？Ann Clin Lab Sci 2016;46:260-265. 

    상세보기

34. Hackenhaar FS, Josefsson M, Adolfsson AN, Landfors M, Kauppi K, Hultdin M, et al. Short leukocyte？telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers. Alzheimers Res Ther？2021;13:130. 

35. Palmos AB, Duarte RR, Smeeth DM, Hedges EC, Nixon DF, Thuret S, et al. Telomere length and human？hippocampal neurogenesis. Neuropsychopharmacology 2020;45:2239-2247. 

    상세보기

36. Ashrafi A, Cosentino S, Kang MS, Lee JH, Schupf N, Andersen SL, et al. Leukocyte telomere length is？unrelated to cognitive performance among non-demented and demented persons: an examination of？long life family study participants. J Int Neuropsychol Soc 2020;26:906-917. 

    상세보기

37. Zekry D, Herrmann FR, Irminger-Finger I, Ortolan L, Genet C, Vitale AM, et al. Telomere length is not？predictive of dementia or MCI conversion in the oldest old. Neurobiol Aging 2010;31:719-720. 

    상세보기

38. Rolyan H, Scheffold A, Heinrich A, Begus-Nahrmann Y, Langkopf BH, Holter SM, et al. Telomere？shortening reduces Alzheimer's disease amyloid pathology in mice. Brain 2011;134:2044-2056. 

39. Lee A, Gilbert RM. Epidemiology of Parkinson disease. Neurol Clin 2016;34:955-965. 

40. Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and？pathophysiology. Clin Geriatr Med 2020;36:1-12. 

    상세보기

41. Martin-Ruiz C, Williams-Gray CH, Yarnall AJ, Boucher JJ, Lawson RA, Wijeyekoon RS, et al. Senescence？and inflammatory markers for predicting clinical progression in Parkinson's disease: the ICICLE-PD？study. J Parkinsons Dis 2020;10:193-206. 

42. Wu Y, Pei Y, Yang Z, Li K, Lou X, Cui W. Accelerated telomere shortening independent of LRRK2 variants？in Chinese patients with Parkinson's disease. Aging (Albany NY) 2020;12:20483-20492. 

43. Levstek T, Redensek S, Trost M, Dolzan V, Podkrajsek KT. Assessment of the telomere length and its effect？on the symptomatology of Parkinson's disease. Antioxidants 2021;10:137. 

    상세보기

44. Degerman S, Domellof M, Landfors M, Linder J, Lundin M, Haraldsson S, et al. Long leukocyte telomere？length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism. PLoS One？2014;9:e113387. 

45. Schurks M, Buring J, Dushkes R, Gaziano JM, Zee RY, Kurth T. Telomere length and Parkinson's disease in？men: a nested case-control study. Eur J Neurol 2014;21:93-99. 

    상세보기

46. Wang H, Chen H, Gao X, McGrath M, Deer D, De Vivo I, et al. Telomere length and risk of Parkinson's？disease. Mov Disord 2008;23:302-305. 

47. Hudson G, Faini D, Stutt A, Eccles M, Robinson L, Burn DJ, et al. No evidence of substantia nigra？telomere shortening in Parkinson's disease. Neurobiol Aging 2011;32:2107.e3-2107.e5. 

    상세보기

48. Forero DA, Gonzalez-Giraldo Y, Lopez-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Telomere length？in Parkinson's disease: a meta-analysis. Exp Gerontol 2016;75:53-55. 

    상세보기

49. Khan BK, Yokoyama JS, Takada LT, Sha SJ, Rutherford NJ, Fong JC, et al. Atypical, slowly progressive？behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J？Neurol Neurosurg Psychiatry 2012;83:358-364. 

50. Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral？sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral？Scler Frontotemporal Degener 2017;18:153-174. 

    상세보기

51. Linkus B, Wiesner D, Messner M, Karabatsiakis A, Scheffold A, Rudolph KL, et al. Telomere shortening？leads to earlier age of onset in ALS mice. Aging (Albany NY) 2016;8:382-393. 

52. De Felice B, Annunziata A, Fiorentino G, Manfellotto F, D'Alessandro R, Marino R, et al. Telomerase？expression in amyotrophic lateral sclerosis (ALS) patients. J Hum Genet 2014;59:555-561. 

    상세보기

53. Al Khleifat A, Iacoangeli A, Shatunov A, Fang T, Sproviero W, Jones AR, et al. Telomere length is greater？in ALS than in controls: a whole genome sequencing study. Amyotroph Lateral Scler Frontotemporal？Degener 2019;20:229-234. 

    상세보기

54. Xia K, Zhang L, Zhang G, Wang Y, Huang T, Fan D. Leukocyte telomere length and amyotrophic lateral？sclerosis: a Mendelian randomization study. Orphanet J Rare Dis 2021;16:508. 

    상세보기